ATE322278T1 - Verbindungen aus phyllanthus zur prävention und/oder behandlung von erkrankungen im zusammenhang mit einem retrovirus - Google Patents

Verbindungen aus phyllanthus zur prävention und/oder behandlung von erkrankungen im zusammenhang mit einem retrovirus

Info

Publication number
ATE322278T1
ATE322278T1 AT01986262T AT01986262T ATE322278T1 AT E322278 T1 ATE322278 T1 AT E322278T1 AT 01986262 T AT01986262 T AT 01986262T AT 01986262 T AT01986262 T AT 01986262T AT E322278 T1 ATE322278 T1 AT E322278T1
Authority
AT
Austria
Prior art keywords
retrovirus
phyllanthus
prevention
treatment
compounds
Prior art date
Application number
AT01986262T
Other languages
English (en)
Inventor
Ralf Wagner
Frank Notka
Original Assignee
Phytrix Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytrix Ag filed Critical Phytrix Ag
Application granted granted Critical
Publication of ATE322278T1 publication Critical patent/ATE322278T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/47Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
AT01986262T 2000-10-06 2001-10-05 Verbindungen aus phyllanthus zur prävention und/oder behandlung von erkrankungen im zusammenhang mit einem retrovirus ATE322278T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00121852 2000-10-06
EP01114008 2001-06-08

Publications (1)

Publication Number Publication Date
ATE322278T1 true ATE322278T1 (de) 2006-04-15

Family

ID=26071484

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01986262T ATE322278T1 (de) 2000-10-06 2001-10-05 Verbindungen aus phyllanthus zur prävention und/oder behandlung von erkrankungen im zusammenhang mit einem retrovirus

Country Status (10)

Country Link
US (1) US20040161477A1 (de)
EP (1) EP1333848B1 (de)
JP (1) JP2004513092A (de)
AT (1) ATE322278T1 (de)
AU (1) AU2002220594A1 (de)
CA (1) CA2424869A1 (de)
DE (1) DE60118592T2 (de)
ES (1) ES2261507T3 (de)
PT (1) PT1333848E (de)
WO (1) WO2002028403A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2424930A1 (en) 2000-10-06 2003-04-04 Cmi-Centers For Medical Innovation Ag Method for producing phyllanthus extracts
EP2116253A1 (de) * 2008-05-07 2009-11-11 Phytrix JV, LLC Neuartiger Phyllanthus-Extrakt
WO2011085454A1 (en) * 2010-01-18 2011-07-21 Katholieke Universiteit Leuven K.U.Leuven R&D Gp120 -binding benzene compounds and saccharide compounds
KR101604347B1 (ko) * 2013-07-01 2016-03-17 한국생명공학연구원 피스타시아 웨인마니폴리아 추출물 또는 이의 분획물을 포함하는 염증성 질환의 예방 또는 치료용 약학 조성물
CN103480178B (zh) * 2013-09-30 2016-09-28 新疆大学 一种亚临界水提取雪菊中活性成分的方法
CN103976356B (zh) * 2014-05-07 2015-08-26 王浩 一种减肥食品及其制备方法
CN110665002B (zh) * 2019-10-29 2023-01-24 信阳市动物疫病预防控制中心 一种用于防治牛病毒性腹泻的抗体制剂及其制备方法
CN111658631A (zh) * 2020-06-11 2020-09-15 广东盛普生命科技有限公司 没食子酸及其衍生物和结构类似物在制备抗冠状病毒药物方面的应用
CN112022867B (zh) * 2020-06-18 2022-05-13 浙江省疾病预防控制中心 老鹳草素在制备抗新型冠状病毒药中的应用
EP3954379A1 (de) * 2020-08-12 2022-02-16 HFM - Hybrid Fusion Medicals, GmbH Zusammensetzungen mit phyllanthus-extrakt zur verwendung in der behandlung oder vorbeugung einer sars-cov-2-infektion und/oder mindestens eines symptoms von covid-19

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33275A (en) * 1861-09-10 Improved pipe-joi-nt
US28754A (en) * 1860-06-19 Congress boot
US4388457A (en) * 1982-02-11 1983-06-14 University Patents, Inc. Phyllanthostatin compounds
US4673575A (en) * 1985-04-26 1987-06-16 Fox Chase Cancer Center Composition, pharmaceutical preparation and method for treating viral hepatitus
US4937074A (en) * 1988-03-29 1990-06-26 Fox Chase Cancer Center Method of treating retrovirus infection
WO1990004968A1 (en) * 1988-10-31 1990-05-17 University Of North Carolina At Chapel Hill Inhibition of human retroviruses
US5854233A (en) * 1993-09-08 1998-12-29 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US5529778A (en) * 1994-09-13 1996-06-25 Rohatgi; Surendra Ayurvedic composition for the prophylaxis and treatment of AIDS, flu, TB and other immuno-deficiencies and the process for preparing the same
US5571441A (en) * 1994-11-01 1996-11-05 The Procter & Gamble Company Nutrient supplement compositions providing physiologic feedback
US5648089A (en) * 1995-07-03 1997-07-15 Shawkat; Tarek Extract solution and herbal mixture for treatment of hepatitis
US6136316A (en) * 1996-04-17 2000-10-24 Dabur Research Foundation Hepatoprotective compositions and composition for treatment of conditions related to hepatitis B and E infection
DE19919585A1 (de) * 1999-04-29 2000-12-07 Cmi Ag Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen

Also Published As

Publication number Publication date
DE60118592D1 (de) 2006-05-18
DE60118592T2 (de) 2007-05-16
AU2002220594A1 (en) 2002-04-15
ES2261507T3 (es) 2006-11-16
CA2424869A1 (en) 2002-04-11
JP2004513092A (ja) 2004-04-30
EP1333848B1 (de) 2006-04-05
PT1333848E (pt) 2006-08-31
WO2002028403A1 (en) 2002-04-11
US20040161477A1 (en) 2004-08-19
EP1333848A1 (de) 2003-08-13

Similar Documents

Publication Publication Date Title
WO1998001144A2 (en) Antiviral agents from plant extracts and use for treatment of viral infections
CA2271622A1 (en) Antiviral agents from plant extracts and use for treatment of viral infections
DE60118592D1 (de) Verbindungen aus phyllanthus zur prävention und/oder behandlung von erkrankungen im zusammenhang mit einem retrovirus
DE69632256D1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
RU2007104774A (ru) Комбинация анти-вич ингибиторов обратной транскриптазы и протеазы
EP0376735A3 (de) Zusammensetzung zur Kopfhautbehandlung
AP2000001971A0 (en) Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine.
CA2163348A1 (en) Calanolide and Related Antiviral Compounds, Compositions, and Uses Thereof
BR9911523A (pt) Composto de efavirenz, composição farmacêutica, método para inibição da replicação por uma transcriptase reversa viralmente codificada e método para tratamento da infecção do hiv
WO2005097618A3 (en) Low dose therapy for treating viral infections
ATE182789T1 (de) Arzneimittelzusammensetzung zur prophylaxe und behandlung vorzeitigen samenergusses
GR3024226T3 (en) Antiviral naphthoquinone compounds, compositions and uses thereof.
ATE180259T1 (de) Calanolid antivirale verbindungen, zusammensetzungen und verwendungen davon
EP4321217A3 (de) Substituierte pyridotriazinverbindungen und verwendungen davon
ATE78168T1 (de) Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten.
FR2296426A1 (fr) Elixir
ATE308333T1 (de) Pharmazeutische zusammensetzung zur behandlung von verfrühter ejakulation und/oder von überempfindlichkeit der sexuellen stimulierung
DK0384308T3 (da) Ekstrakt-lægemiddel
DE60033699D1 (de) Kräuterzusammensetzung enthaltend calendula und eucalyptus für die behandlung und heilung von erkrankungen
DE69223152T2 (de) Buchsbaum zubereitung für die behandlung von hiv infektion
AU2880495A (en) Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
BR0207931A (pt) Anticorpos naturais ativos contra vìrus hiv
RU93047363A (ru) Лечебно-профилактическое средство широкого спектра действия
MY157594A (en) Compositions of matter useful in the treatment of viral infections derived from plant extracts
FR2745184A1 (fr) Utilisation de la lecithine de soja pour la preparation d' un medicament contre le sida

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1333848

Country of ref document: EP

REN Ceased due to non-payment of the annual fee